Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Diagnostic Technologies: Page 2
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.
March 15, 2023
Molecular test in study identified hypnotizable patients for postoperative pain treatment
A molecular point-of-care test identified individuals for whom hypnosis may relieve postoperative pain, potentially reducing opioid use.
March 15, 2023
Bionano Laboratories launches new optical genome mapping tests
These tests offer genome-wide assessment of structural variants (SVs) and testing for most common and rare chromosomal abnormalities to assist clinicians in both diagnosing and managing their patients’ medical conditions.
March 15, 2023
Swedish study shows blood test may help in evaluating epilepsy
High levels of immune proteins before and after epileptic seizures may serve as epilepsy biomarkers that can be identified with a simple blood test.
March 14, 2023
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Glow-in-the-dark proteins, developed from the luciferase found in bioluminescent creatures, may make viral disease diagnosis quicker and easier, according to the researchers.
March 15, 2023
Noze nabs $1M grant from Bill & Melinda Gates Foundation to develop breath testing platform
The aim is to develop a platform that enables rapid screening and diagnostic testing for infectious diseases such as malaria and tuberculosis that impact millions of people, particularly in developing countries, Noze said.
March 14, 2023
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
Paige, Leica Biosystems expand partnership to enhance digital pathology workflows
Under the partnership, a co-branded version of Paige’s pathology platform will be introduced as the core interface between pathologists and Leica Biosystems hardware.
March 13, 2023
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Through the partnership, the Sophia DDM Platform will be integrated with Agilent’s research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.
March 14, 2023
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Long COVID less likely after Omicron than after original virus, Swiss researchers find
In a Swiss study, investigators have found that long COVID is less likely after Omicron infection than after infection by the original wild-type SARS-CoV-2 virus.
March 9, 2023
Spectrum Healthcare Partners adopts Proscia digital pathology platform
The addition of Proscia's Concentriq Dx digital platform will allow Spectrum Healthcare Partners to expand the reach of its experts across the healthcare systems it serves in Maine and New Hampshire.
March 13, 2023
QuidelOrtho nabs FDA de novo authorization for COVID-19 lateral flow immunofluorescent assay
Sofia 2 SARS Antigen+ FIA is a lateral flow immunofluorescent assay used with the firms Sofia 2 fluorescent immunoassay analyzer.
March 8, 2023
Previous Page
Page 2 of 275
Next Page